Trial Outcomes & Findings for Efficacy Study to Evaluate Laparoscopic Fascial Closure Device (NCT NCT01024296)

NCT ID: NCT01024296

Last Updated: 2017-10-12

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

4 participants

Primary outcome timeframe

Day 1, at the end of surgery

Results posted on

2017-10-12

Participant Flow

Participant milestones

Participant milestones
Measure
Gastric Bypass Surgery Patients
Port Close: Device for applying loop suture to close surgical site
Overall Study
STARTED
4
Overall Study
COMPLETED
4
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Efficacy Study to Evaluate Laparoscopic Fascial Closure Device

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Gastric Bypass Surgery Patients
n=4 Participants
Port Close: Device for applying loop suture to close surgical site
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
4 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 1, at the end of surgery

Outcome measures

Outcome measures
Measure
Gastric Bypass Surgery Patients
n=4 Participants
Port Close: Device for applying loop suture to close surgical site
Count of Participants With Successful Port Site Closure Using Port Close Device
3 Participants

PRIMARY outcome

Timeframe: Day 1, from insertion to removal of Port Close device during surgery

Population: Participants with successful closure using the Port Close device were included in the analysis.

Outcome measures

Outcome measures
Measure
Gastric Bypass Surgery Patients
n=3 Participants
Port Close: Device for applying loop suture to close surgical site
Time of Port Site Closure
138.7 seconds
Standard Deviation 22.21

Adverse Events

Gastric Bypass Surgery Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Bilal M Shafi, MD

Stanford University

Phone: (215) 738-0400

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place